Evaluation of the CCL17/CCL22-CCR4 axis in pediatrics with B-cell acute lymphoblastic leukemia before and after a chemotherapy course.

Autor: Motaghi M; Department of Hematology and Blood Banking, Kerman University of Medical Sciences, Kerman, Iran., Jafarzadeh A; Department of Immunology, Medical School, Kerman University of Medical Sciences, Kerman, Iran; Immunology of Infectious Diseases Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran. Electronic address: Jafarzadeh14@yahoo.com., Farsinejad A; Department of Hematology and Blood Banking, Kerman University of Medical Sciences, Kerman, Iran., Norouzi A; Molecular Medicine Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran., Khorramdelazad H; Department of Immunology, Faculty of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran., Farahmandinia Z; Department of Pediatrics, Afzalipour Hospital, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran., Afgar A; Research Center for Hydatid Disease in Iran, Kerman University of Medical Sciences, Kerman, Iran., Hassanshahia G; Molecular Medicine Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran. Electronic address: ghassanshahi@gmail.com.

Publikováno v: Cytokine [Cytokine] 2024 Oct; Vol. 182, pp. 156721. Date of Electronic Publication: 2024 Aug 05.

Daratumumab in pediatric relapsed/refractory acute lymphoblastic leukemia or lymphoblastic lymphoma: the DELPHINUS study.

Autor: Bhatla T; Department of Pediatrics, Children's Hospital of New Jersey, Newark Beth Israel Medical Center, Newark, NJ., Hogan LE; Department of Pediatrics, Stony Brook Children's, Stony Brook, NY., Teachey DT; Division of Oncology, Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Bautista F; Department of Pediatric Hematology-Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Hematology-Oncology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain., Moppett J; Paediatric Haematology, Bristol Royal Hospital for Children, Bristol, United Kingdom., Velasco Puyó P; Department of Pediatric Hematology-Oncology, Vall d'Hebron Hospital, Barcelona, Spain., Micalizzi C; Clinical Experimental Haematology Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy., Rossig C; Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany., Shukla N; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY., Gilad G; Department of Pediatric Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Locatelli F; Department of Pediatric Hematology and Oncology, IRCCS Ospedale Pediatrico Bambino Gesù, Catholic University of the Sacred Heart, Rome, Italy., Baruchel A; Pediatric Hematology and Immunology Department, Robert Debré University Hospital, Assistance Publique-Hôpitaux de Paris and Université de Paris Cité, Paris, France., Zwaan CM; Department of Pediatric Hematology-Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands., Bezler NS; Division of Hematology and Oncology, Connecticut Children's, University of Connecticut School of Medicine, Hartford, CT., Rubio-San-Simón A; Department of Pediatric Hematology-Oncology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain., Taussig DC; Centre for Molecular Pathology, The Royal Marsden Hospital, Institute of Cancer Research, Sutton, United Kingdom., Raetz EA; Department of Pediatrics, New York University Langone Health, New York, NY., Mao ZJ; Department of Laboratory Medicine, University of Washington, Seattle, WA., Wood BL; Department of Laboratory Medicine, University of Washington, Seattle, WA., Alvarez Arias D; Janssen Research and Development, LLC, Spring House, PA., Krevvata M; Janssen Research and Development, LLC, Spring House, PA., Nnane I; Janssen Research and Development, LLC, Spring House, PA., Bandyopadhyay N; Janssen Research and Development, LLC, Raritan, NJ., Lopez Solano L; Janssen Research and Development, LLC, Raritan, NJ., Dennis RM; Janssen Research and Development, LLC, Raritan, NJ., Carson R; Janssen Research and Development, LLC, Spring House, PA., Vora A; Department of Haematology, Great Ormond Street Hospital for Children, London, United Kingdom.

Publikováno v: Blood [Blood] 2024 Nov 21; Vol. 144 (21), pp. 2237-2247.

Long-Term Survival and Immune Reconstitution of Donor-Derived Chimeric Antigen Receptor T-Cell Therapy for Childhood Molecular Relapse of B-Cell Acute Lymphoblastic Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation.

Autor: Hu GH; National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking-Tsinghua Center for Life Science, Research Unit of Key Technique for Diagnosis and Treatment of Hematologic Malignancies, Chinese Academic of Medical Sciences, Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China., Zuo YX; National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking-Tsinghua Center for Life Science, Research Unit of Key Technique for Diagnosis and Treatment of Hematologic Malignancies, Chinese Academic of Medical Sciences, Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China., Suo P; National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking-Tsinghua Center for Life Science, Research Unit of Key Technique for Diagnosis and Treatment of Hematologic Malignancies, Chinese Academic of Medical Sciences, Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China., Bai L; National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking-Tsinghua Center for Life Science, Research Unit of Key Technique for Diagnosis and Treatment of Hematologic Malignancies, Chinese Academic of Medical Sciences, Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China., Zhang XH; National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking-Tsinghua Center for Life Science, Research Unit of Key Technique for Diagnosis and Treatment of Hematologic Malignancies, Chinese Academic of Medical Sciences, Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China., Wang Y; National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking-Tsinghua Center for Life Science, Research Unit of Key Technique for Diagnosis and Treatment of Hematologic Malignancies, Chinese Academic of Medical Sciences, Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China., Cheng YF; National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking-Tsinghua Center for Life Science, Research Unit of Key Technique for Diagnosis and Treatment of Hematologic Malignancies, Chinese Academic of Medical Sciences, Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China., Huang XJ; National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking-Tsinghua Center for Life Science, Research Unit of Key Technique for Diagnosis and Treatment of Hematologic Malignancies, Chinese Academic of Medical Sciences, Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.

Publikováno v: Pediatric hematology and oncology [Pediatr Hematol Oncol] 2024 Nov; Vol. 41 (8), pp. 583-595. Date of Electronic Publication: 2024 Oct 03.

Flow cytometry for meningeal infiltration in B acute lymphoblastic leukemia in a low middle income country.

Autor: Anane E; Biological hematology department, Aziza Othmana University Hospital, Tunis, Tunisia.; Faculty of Medicine of Tunis, University Tunis El Manar, Tunis, Tunisia., Lakhal FB; Biological hematology department, Aziza Othmana University Hospital, Tunis, Tunisia.; Faculty of Medicine of Tunis, University Tunis El Manar, Tunis, Tunisia., Salem SF; Biological hematology department, Aziza Othmana University Hospital, Tunis, Tunisia., Ghali O; Biological hematology department, Aziza Othmana University Hospital, Tunis, Tunisia.; Faculty of Medicine of Tunis, University Tunis El Manar, Tunis, Tunisia., Feki E; Biological hematology department, Aziza Othmana University Hospital, Tunis, Tunisia., Abdennebi YB; Faculty of Medicine of Tunis, University Tunis El Manar, Tunis, Tunisia.; Department of Hematology, Aziza Othmana University Hospital, Tunis, Tunisia., Bahri M; Faculty of Medicine of Tunis, University Tunis El Manar, Tunis, Tunisia.; Department of Hematology, Aziza Othmana University Hospital, Tunis, Tunisia., Azza E; Faculty of Medicine of Tunis, University Tunis El Manar, Tunis, Tunisia.; Department of Hematology, Aziza Othmana University Hospital, Tunis, Tunisia., Aissaoui L; Faculty of Medicine of Tunis, University Tunis El Manar, Tunis, Tunisia.; Department of Hematology, Aziza Othmana University Hospital, Tunis, Tunisia., El Borgi W; Biological hematology department, Aziza Othmana University Hospital, Tunis, Tunisia.; Faculty of Medicine of Tunis, University Tunis El Manar, Tunis, Tunisia., Gouider E; Biological hematology department, Aziza Othmana University Hospital, Tunis, Tunisia.; Faculty of Medicine of Tunis, University Tunis El Manar, Tunis, Tunisia.

Publikováno v: Cytometry. Part B, Clinical cytometry [Cytometry B Clin Cytom] 2024 Sep; Vol. 106 (5), pp. 405-411. Date of Electronic Publication: 2024 May 06.

[Prognostic analysis of childhood T-lymphoblastic lymphoma treated with leukemia regimen].

Autor: Hou SM; Department of Hematology/Oncology, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200040, China., Shao JB; Department of Hematology/Oncology, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200040, China., Li H; Department of Hematology/Oncology, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200040, China., Zhang N; Department of Hematology/Oncology, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200040, China., Zhu JS; Department of Hematology/Oncology, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200040, China., Wang D; Department of Hematology/Oncology, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200040, China., Fu P; Department of Hematology/Oncology, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200040, China.

Publikováno v: Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics [Zhongguo Dang Dai Er Ke Za Zhi] 2024 May 15; Vol. 26 (5), pp. 469-475.